244 related articles for article (PubMed ID: 23171075)
21. Dengue protease activity: the structural integrity and interaction of NS2B with NS3 protease and its potential as a drug target.
Phong WY; Moreland NJ; Lim SP; Wen D; Paradkar PN; Vasudevan SG
Biosci Rep; 2011 Oct; 31(5):399-409. PubMed ID: 21329491
[TBL] [Abstract][Full Text] [Related]
22. Activation of dengue protease autocleavage at the NS2B-NS3 junction by recombinant NS3 and GST-NS2B fusion proteins.
Wu CF; Wang SH; Sun CM; Hu ST; Syu WJ
J Virol Methods; 2003 Dec; 114(1):45-54. PubMed ID: 14599678
[TBL] [Abstract][Full Text] [Related]
23. In vitro evaluation of novel inhibitors against the NS2B-NS3 protease of dengue fever virus type 4.
Nguyen TT; Lee S; Wang HK; Chen HY; Wu YT; Lin SC; Kim DW; Kim D
Molecules; 2013 Dec; 18(12):15600-12. PubMed ID: 24352016
[TBL] [Abstract][Full Text] [Related]
24. A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease.
Yang CC; Hu HS; Wu RH; Wu SH; Lee SJ; Jiaang WT; Chern JH; Huang ZS; Wu HN; Chang CM; Yueh A
Antimicrob Agents Chemother; 2014; 58(1):110-9. PubMed ID: 24145533
[TBL] [Abstract][Full Text] [Related]
25. Cysteine Disulfide Traps Reveal Distinct Conformational Ensembles in Dengue Virus NS2B-NS3 Protease.
Hill ME; Yildiz M; Hardy JA
Biochemistry; 2019 Feb; 58(6):776-787. PubMed ID: 30472839
[TBL] [Abstract][Full Text] [Related]
26. Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence.
Piccirillo E; Merget B; Sotriffer CA; do Amaral AT
J Comput Aided Mol Des; 2016 Mar; 30(3):251-70. PubMed ID: 26923377
[TBL] [Abstract][Full Text] [Related]
27. In vitro determination of dengue virus type 2 NS2B-NS3 protease activity with fluorescent peptide substrates.
Khumthong R; Angsuthanasombat C; Panyim S; Katzenmeier G
J Biochem Mol Biol; 2002 Mar; 35(2):206-12. PubMed ID: 12297031
[TBL] [Abstract][Full Text] [Related]
28. Antiviral activities of 15 dengue NS2B-NS3 protease inhibitors using a human cell-based viral quantification assay.
Chu JJ; Lee RC; Ang MJ; Wang WL; Lim HA; Wee JL; Joy J; Hill J; Brian Chia CS
Antiviral Res; 2015 Jun; 118():68-74. PubMed ID: 25823617
[TBL] [Abstract][Full Text] [Related]
29. Dengue virus type 2 NS3 protease and NS2B-NS3 protease precursor induce apoptosis.
Shafee N; AbuBakar S
J Gen Virol; 2003 Aug; 84(Pt 8):2191-2195. PubMed ID: 12867651
[TBL] [Abstract][Full Text] [Related]
30. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
Sarwar MW; Riaz A; Dilshad SMR; Al-Qahtani A; Nawaz-Ul-Rehman MS; Mubin M
BMC Struct Biol; 2018 Apr; 18(1):6. PubMed ID: 29673347
[TBL] [Abstract][Full Text] [Related]
31. In silico evaluation of inhibitory potential of triterpenoids from Azadirachta indica against therapeutic target of dengue virus, NS2B-NS3 protease.
Dwivedi VD; Tripathi IP; Mishra SK
J Vector Borne Dis; 2016; 53(2):156-61. PubMed ID: 27353586
[TBL] [Abstract][Full Text] [Related]
32. A small compound targeting the interaction between nonstructural proteins 2B and 3 inhibits dengue virus replication.
Pambudi S; Kawashita N; Phanthanawiboon S; Omokoko MD; Masrinoul P; Yamashita A; Limkittikul K; Yasunaga T; Takagi T; Ikuta K; Kurosu T
Biochem Biophys Res Commun; 2013 Oct; 440(3):393-8. PubMed ID: 24070610
[TBL] [Abstract][Full Text] [Related]
33. Doxycycline Interferes with Zika Virus Serine Protease and Inhibits Virus Replication in Human Skin Fibroblasts.
Chong Teoh T; J Al-Harbi S; Abdulrahman AY; Rothan HA
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299596
[TBL] [Abstract][Full Text] [Related]
34. Pharmacophoric characteristics of dengue virus NS2B/NS3pro inhibitors: a systematic review of the most promising compounds.
Leonel CA; Lima WG; Dos Santos M; Ferraz AC; Taranto AG; de Magalhães JC; Dos Santos LL; Ferreira JMS
Arch Virol; 2018 Mar; 163(3):575-586. PubMed ID: 29147793
[TBL] [Abstract][Full Text] [Related]
35. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
[TBL] [Abstract][Full Text] [Related]
36. Effects of NS2B-NS3 protease and furin inhibition on West Nile and Dengue virus replication.
Kouretova J; Hammamy MZ; Epp A; Hardes K; Kallis S; Zhang L; Hilgenfeld R; Bartenschlager R; Steinmetzer T
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):712-721. PubMed ID: 28385094
[TBL] [Abstract][Full Text] [Related]
37. A comparative biochemical analysis of the NS2B(H)-NS3pro protease complex from four dengue virus serotypes.
Iempridee T; Thongphung R; Angsuthanasombat C; Katzenmeier G
Biochim Biophys Acta; 2008; 1780(7-8):989-94. PubMed ID: 18439431
[TBL] [Abstract][Full Text] [Related]
38. Identification of novel thiadiazoloacrylamide analogues as inhibitors of dengue-2 virus NS2B/NS3 protease.
Liu H; Wu R; Sun Y; Ye Y; Chen J; Luo X; Shen X; Liu H
Bioorg Med Chem; 2014 Nov; 22(22):6344-52. PubMed ID: 25438757
[TBL] [Abstract][Full Text] [Related]
39. Enzymatic analysis of recombinant Japanese encephalitis virus NS2B(H)-NS3pro protease with fluorogenic model peptide substrates.
Junaid M; Chalayut C; Sehgelmeble Torrejon A; Angsuthanasombat C; Shutava I; Lapins M; Wikberg JE; Katzenmeier G
PLoS One; 2012; 7(5):e36872. PubMed ID: 22615830
[TBL] [Abstract][Full Text] [Related]
40. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA
J Virol; 2017 May; 91(10):. PubMed ID: 28298600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
